The analysis of specific immune response for borrelia burgdorferi according to in vivo antigens in regard to symptoms subjectively perceived by foresters

• Autorzy: Tokarska-Rodak M. , Koziol-Montewka M. , Plewik D. , Paszkiewicz J. , Szepeluk A. , Panczuk A.

Warianty tytułu

EN

The analysis of appearing and disappearing dynamics of antibodies for borrelia burgdorferi antigenic protein from in vivo group among forest service employees on the basis of two-stage studies

• Języki publikacji: EN

Abstrakty

EN

The aim of our this work was analysis of specific immune response for B. burgdorferi according to in vivo antigens in regard to symptoms subjectively perceived by foresters, in 2009 and 2012. Material and methods: study group include 41 foresters (19 - 86 years old), from the forest district in Lubelskie region. All persons underwent serological diagnostic. We used  2 phase diagnosis  method of Lyme diseases according to standards. Used tests include Borrelia antigens from in vivo group, which are not use in standard diagnosis test. The study was carried out in 2009 and then again in 2012. Results: The analysis of antibodies for Borrelia proteins, including the in vivo, demonstrated how active, long-term and time-variable is the process of B. burgdorferi infection. Conclusions: The expression of Borrelia proteins and high immunogenicity translates into effectiveness of diagnostic procedures concerning B. burgdorferi identification. Considering to not clear clinical manifestation and changeable immune response require individual approach to each patient.

• Wydawca: -
• Czasopismo: Health Problems of Civilization
• Rocznik: 2014
• Tom: 08
• Numer: 1
• Opis fizyczny: p.32-38,ref.

Twórcy

autor

Tokarska-Rodak M.

• Department of Medical Microbiology, Medical University of Lublin, Chodzki 1, 20-093 Lublin, Poland
• Department for Health, Pope John Paul II State School of Higher Education in Biala Podlaska, Biala Podlaska, Poland

autor

Koziol-Montewka M.

• Department of Medical Microbiology, Medical University of Lublin, Lublin, Poland
• Department for Health, Pope John Paul II State School of Higher Education in Biala Podlaska, Biala Podlaska, Poland

autor

Plewik D.

• Innovation Research Center, Pope John Paul II State School of Higher Education in Biala Podlaska, Biala Podlaska, Poland

autor

Paszkiewicz J.

• Department for Health, Pope John Paul II State School of Higher Education in Biala Podlaska, Biala Podlaska, Poland

autor

Szepeluk A.

• Innovation Research Center, Pope John Paul II State School of Higher Education in Biala Podlaska, Biala Podlaska, Poland

autor

Panczuk A.

• Department for Health, Pope John Paul II State School of Higher Education in Biala Podlaska, Biala Podlaska, Poland

Bibliografia

• 1. Aberer E. (2007), Lyme borreliosis - an update. Journal der Deutschen Dermatologischen Gesellschsft, 5, 5, s. 406-413.
• 2. Aguero-Rosenfeld M.E., Wang G., Schwarz I., Womser G.P. (2005), Diagnosis of Lyme borreliosis. Clin.Microbiol. Rev. 18, 3, s. 484-509.
• 3. Bárcena-Uribarri I., Tein M., Bonde M. (2012), Porins in the Genus Borrelia. W: A. Karami (red.), Lyme disease. INTECH, s. 139-160.
• 4. Bykowski T., Woodman M.E., Cooley A.E. (2008), Borrelia burgdorferi complement regulator-acquiring surface proteins (BbCRASPs): Expression patterns during the mammal-tick infection cycle. I.J.M.M. 298, Supl 1, s. 249-256.
• 5. Chmielewska-Badora J., Cisak E., Wójcik-Fatla A., Zwoliński J., Buczek A., Dutkiewicz J. (2006), Correlation of tests detection of Borrelia burgdorferi sensu lato infection in patients with diagnosed borreliosis. Ann. Agric. Environ. Med. 2006, 13, s. 307-311.
• 6. Hofmann H., Wallach R., Lorenz I., Bechtel, M. (2006), Comparison of a New line assay using purified and recombinant antigens with a European lysate blot for serodiagnosis of Lyme borreliosis. I.J.M.M. 296, s. 288-290.
• 7. Lakos A., Igari E. (2012), Advancement in Borrelia burgdorferi antibody testing: Ccomparative Immunoblot Assay (COMPASS). W: A. Karami (red.), Lyme disease. INTECH, s. 55-78.
• 8. Singh S. K., Girschick H. J. (2004), Molecular survival strategies of the Lyme disease spirochete Borrelia burgdorferi. Lancet Inf Dis, 4, s. 4575-83
• 9. Tokarska-Rodak M., Fota-Markowska H., Śmiechowicz F., Gajownik, B., Prokop, M., Modrzewska, R., Kozioł-Montewka, M. (2010), Antibodies against in vivo B. burgdorferi antigens evaluated in patients with Lyme arthritis with reference to treatment. Adv. Clin. Exp. Med. 19, 4, s. 489-496.
• 10. Tokarska-Rodak M., Kozioł-Montewka M., Fota-Markowska H., Bielec, D., Modrzewska, R., Pańczuk, A. (2008), Frequency and specificity of the antibodies against Borrelia burgdorferi tested by Western blot method in patients with symptoms of arthritis. Cent. Eur. J. Immunol. 33, 4, s. 220-223.
• 11. Von Lackum K., Miller J.C., Bykowski T. (2005), Borrelia burgdorferi regulates expression of Complement Regulator-Acquiring Surface Protein 1 during the mammal-tick infection cycle. Infect. Immun. 73, 11, s. 7398-7405.
• 12. Wilske B., Fingerle V., Schulze-Spechtel U. (2007), Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol. Med. Microbiol. 49, s. 13-21.
• 13. Zajkowska J., Kondrusik M., Pancewicz S.A., Sienkiewicz, I., Grygorczuk S. Wierzbińska R., Hermanowska-Szpakowicz T. (2006), Laboratory diagnosis of Early Lyme borreliosis – comparison of ELISA, Western blot (EcoLine), and PCR results. I. J Med. Microbiol. 296, s. 291-293.
• 14. Zajkowska J., Kondrusik M., Pancewicz S., Grygorczuk S., Wierzbińska R., Hermanowska-Szpakowicz T., Czeczuga A., Sienkiewicz I. (2006), Test Western blot z białkiem VlsE oraz antygenami „in vivo” w diagnostyce boreliozy z Lyme. Przegl. Epidemiol. 60, s. 177-185.
• 15. Van Burgel N., Kraiczy P., Schuijt T., Zipfel P.F., van Dam A.P. (2010), Identification and functional characterization of Complement Regulator Acquiring Surface Protein -1 of serum resistant Borrelia garinii OspA serotype 4. BMC Mikrobiol. 10.43. <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833144/>, (10 lipca 2013). Cytowanie w tekście (van Burgel, 2010)
• 16. European Concerted Action on Lyme Borreliosis (2008), http://meduni09.edis.at/eucalb/cms/index.php?option=com_content&task=view&id=38&Itemid=102, (20 lipca 2011). Cytowanie w tekście (EUCALB, 2008)
• 17. Coburn J., Leong J., Chaconas G. (2013), Illuminating the roles of the Borrelia burgdorferi adhesins.Trends.Microbiol. <http://www.cell.com/trends/microbiology//retrieve/pii/S0966842X13001145?_returnURL=http://linkinghub.elsevier.com/retrieve/pii/S0966842X13001145?showall=true>, (30 lipca 2013). Cytowanie w tekście (Coburg, 2013)
• 18. Siegel C., Hallström T., Skerka Ch., Eberhardt, H., Uzonyi, B., Beckhaus, T., Karas, M. (2010), Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi. <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958145/?tool=pubmed>, (03 sierpień 2013). Cytowanie w tekście (Siegel, 2010)
• 19. Centers for Disease Control and Prevention. http://www.cdc.gov/lyme/, (14 września 2011). Cytowanie w tekście (CDC, 2011)

Uwagi

PL

Rekord w opracowaniu